249 related articles for article (PubMed ID: 25703117)
1. Drug delivery and release systems for targeted tumor therapy.
Böhme D; Beck-Sickinger AG
J Pept Sci; 2015 Mar; 21(3):186-200. PubMed ID: 25703117
[TBL] [Abstract][Full Text] [Related]
2. Protein- and Peptide-drug conjugates: an emerging drug delivery technology.
Vhora I; Patil S; Bhatt P; Misra A
Adv Protein Chem Struct Biol; 2015; 98():1-55. PubMed ID: 25819275
[TBL] [Abstract][Full Text] [Related]
3. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
4. Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate.
Lelle M; Kaloyanova S; Freidel C; Theodoropoulou M; Musheev M; Niehrs C; Stalla G; Peneva K
Mol Pharm; 2015 Dec; 12(12):4290-300. PubMed ID: 26524088
[TBL] [Abstract][Full Text] [Related]
5. Peptide-drug conjugate-based novel molecular drug delivery system in cancer.
Zhu YS; Tang K; Lv J
Trends Pharmacol Sci; 2021 Oct; 42(10):857-869. PubMed ID: 34334251
[TBL] [Abstract][Full Text] [Related]
6. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
Dal Corso A; Pignataro L; Belvisi L; Gennari C
Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915
[TBL] [Abstract][Full Text] [Related]
7. Smart linkers in polymer-drug conjugates for tumor-targeted delivery.
Chang M; Zhang F; Wei T; Zuo T; Guan Y; Lin G; Shao W
J Drug Target; 2016; 24(6):475-91. PubMed ID: 26560242
[TBL] [Abstract][Full Text] [Related]
8. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
9. Small targeted cytotoxics from DNA-encoded chemical libraries.
Samain F; Casi G
Curr Opin Chem Biol; 2015 Jun; 26():72-9. PubMed ID: 25726911
[TBL] [Abstract][Full Text] [Related]
10. Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil.
Jin Q; Mitschang F; Agarwal S
Biomacromolecules; 2011 Oct; 12(10):3684-91. PubMed ID: 21863834
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
12. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
[TBL] [Abstract][Full Text] [Related]
13. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells.
Tung WL; Hu SH; Liu DM
Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of polyethylenimine-based nanocarriers for systemic tumor targeting of nucleic acids.
Rödl W; Schaffert D; Wagner E; Ogris M
Methods Mol Biol; 2013; 948():105-20. PubMed ID: 23070766
[TBL] [Abstract][Full Text] [Related]
16. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
17. Design of self-immolative linkers for tumour-activated prodrug therapy.
Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
[TBL] [Abstract][Full Text] [Related]
18. "Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.
Gilad Y; Firer MA; Rozovsky A; Ragozin E; Redko B; Albeck A; Gellerman G
Eur J Med Chem; 2014 Oct; 85():139-46. PubMed ID: 25084142
[TBL] [Abstract][Full Text] [Related]
19. Magnetic therapeutic delivery using navigable agents.
Martel S
Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
[TBL] [Abstract][Full Text] [Related]
20. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
